Abnormally Expressed Ferroptosis-Associated FANCD2 in Mediating the Temozolomide Resistance and Immune Response in Glioblastoma
Ferroptosis-related genes (FRGs) have been identified as potential targets involved in oncogenesis and cancer therapeutic response. Nevertheless, the specific roles and underlying mechanisms of FRGs in GBM and temozolomide (TMZ) resistance remain unclear. Through comprehensive bioinformatics, we fou...
Saved in:
Main Authors: | Liying Song (Author), Jiali Wu (Author), Hua Fu (Author), Cuifang Wu (Author), Xiaopei Tong (Author), Mingyu Zhang (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nose-to-brain delivery of temozolomide-loaded PLGA nanoparticles functionalized with anti-EPHA3 for glioblastoma targeting
by: Liuxiang Chu, et al.
Published: (2018) -
Aberrant Expression of ADARB1 Facilitates Temozolomide Chemoresistance and Immune Infiltration in Glioblastoma
by: Can Lu, et al.
Published: (2022) -
Nanocell-mediated delivery of miR-34a counteracts temozolomide resistance in glioblastoma
by: Muhammad Babar Khan, et al.
Published: (2021) -
Polydopamine-based loaded temozolomide nanoparticles conjugated by peptide-1 for glioblastoma chemotherapy and photothermal therapy
by: Hao Wu, et al.
Published: (2023) -
Advances in the management of glioblastoma: the role of temozolomide and MGMT testing
by: Thomas RP, et al.
Published: (2012)